CIDM Cinedigm Corporation

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES                                                                                   
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940                       

1. Name and Address of Reporting Person * MCGURK CHRISTOPHER J	2. Issuer Name and Ticker or Trading Symbol Cinedigm Corp. [ CIDM ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) CEO and Chairman
(Last)          (First)          (Middle) C/O CINEDIGM CORP., 237 WEST 35TH STREET, SUITE 605	3. Date of Earliest Transaction (MM/DD/YYYY) 11/19/2020
(Street) NEW YORK, NY 10001 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock								781740	D
Class A Common Stock								382333	I	By Christopher and Jamie McGurk Living Trust (1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	(2)							(2)	12/23/2020	Class A Common Stock	450000		450000	D
Stock Options (Right to Buy)	$14.00							(3)	8/22/2023	Class A Common Stock	150000		150000	D
Stock Appreciation Right	$1.47							(4)	6/7/2028	Class A Common Stock	700000		700000	D
Stock Appreciation Rights	$.54	11/19/2020		A		2500000		(5)	11/19/2030	Class A Common Stock	2500000	$0	2500000	D

Explanation of Responses:
(1)	The reporting person is a trustee of the Christopher and Jamie McGurk Living Trust.
(2)	These options are grouped in three tranches, consisting of 150,000 having an exercise price of $15.00, 250,000 having an exercise price of $30.00 and 50,000 having an exercise price of $50.00. One-third of the options in each tranche vested on December 23 of each of 2011, 2012 and 2013.
(3)	One-third of the options vested on March 31of each of 2015, 2016 and 2017.
(4)	One-third of the stock appreciation right will vest on March 31 of each of 2019, 2020 and 2021.
(5)	1,250,000 of the SARs vested on November 19, 2020 and 1,250,000 of the SARs vest on March 31, 2023.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
MCGURK CHRISTOPHER J C/O CINEDIGM CORP. 237 WEST 35TH STREET, SUITE 605 NEW YORK, NY 10001	X		CEO and Chairman

Signatures
/s/ Christopher McGurk		11/23/2020
**Signature of Reporting Person		Date